The Efficacy of Calcium Carbonate-Vitamin D3 in Pregnant Women for the Prevention of Hypertensive Disorders in Pregnancy
- PMID: 35990835
- PMCID: PMC9388239
- DOI: 10.1155/2022/7971976
The Efficacy of Calcium Carbonate-Vitamin D3 in Pregnant Women for the Prevention of Hypertensive Disorders in Pregnancy
Retraction in
-
Retracted: The Efficacy of Calcium Carbonate-Vitamin D3 in Pregnant Women for the Prevention of Hypertensive Disorders in Pregnancy.Evid Based Complement Alternat Med. 2023 Jun 21;2023:9756870. doi: 10.1155/2023/9756870. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37387914 Free PMC article.
Abstract
Objective: To evaluate the efficacy of calcium carbonate-vitamin D3 in pregnant women for the prevention of hypertensive disorders in pregnancy.
Methods: Between April 2020 and June 2021, 60 pregnant women undergoing prenatal examinations in our hospital were recruited and assigned via the random number table method at a ratio of 1 : 1 to receive conventional pregnancy care (observation group) or conventional pregnancy care plus calcium carbonate-vitamin D3 administration (experimental group). Outcome measures included blood pressure, blood calcium, the occurrence of hypertensive disorders, and adverse events.
Results: The diastolic blood pressure (DBP) and systolic blood pressure (SBP) levels at delivery in the experimental group were significantly lower than those in the observation group (P < 0.05). Pregnant women in the experimental group had significantly higher blood calcium levels at labor than those in the observation group (P < 0.05). The administration of calcium carbonate-vitamin D3 resulted in a significantly lower incidence of hypertensive disorders and adverse events versus conventional pregnancy care (P < 0.05).
Conclusion: The effect of calcium carbonate-vitamin D3 administration during pregnancy for the prevention of hypertensive disorders is significant, which effectively improves the blood calcium level of pregnant women and reduces the occurrence of adverse events, so it is worthy of clinical promotion and application.
Copyright © 2022 Zhen Chen and Jing Chen.
Conflict of interest statement
All the authors declare that they have no financial conflicts of interest.
Figures
References
-
- Zhang J. Efficacy observation of Pinggan Xifeng decoction in adjuvant treatment of hypertensive disorders in pregnancy. Clinical Research in Traditional Chinese Medicine . 2020;12(25):113–115.
-
- Cheng X., Yuan M., Liu H. Efficacy of Yiqi Yangyin Decoction in the treatment of gestational hypertension and its effect on serological indexes of patients. Hainan Medical Journal . 2019;30(23):3034–3037.
-
- Wang R. Clinical study on Ziyin Xifeng Decoction combined with conventional therapy in the treatment of gestational hypertension. New Chinese Medicine . 2019;51(12):172–174.
-
- Chunyun W. Clinical observation of Pinggan Xifeng Decoction in adjuvant treatment of gestational hypertension. Bright Chinese Medicine . 2021;36(14):2292–2294.
-
- Liu Y. Intervention effect of calcium combined with aspirin on pregnant women with high risk of gestational hypertension. Journal of Clinical Rational Medicine . 2021;14(31):93–95.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
